Global Pertussis Vaccine Market Report (2026–2036)
Market Overview
The global pertussis vaccine market is projected to grow steadily during 2026–2036, driven by rising incidences of whooping cough, increasing immunization programs worldwide, and growing awareness of preventive healthcare. Pertussis vaccines are critical components of childhood immunization schedules and are often administered in combination with diphtheria and tetanus vaccines (DTaP). Advances in acellular vaccine formulations and government-supported vaccination campaigns are expected to sustain market growth.
Key Players
In addition to the listed manufacturers, the following companies are also significant participants in the global pertussis vaccine market:
- GlaxoSmithKline Plc (UK)
- Sanofi Pasteur (France)
- Pfizer Inc. (US)
- Novartis AG (Switzerland)
- Emergent BioSolutions (US)
- China National Biotec Group (China)
- Serum Institute of India Pvt. Ltd. (India)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Biological E Limited (India)
- Panacea Biotec (India)
These players compete on vaccine efficacy, distribution networks, regulatory approvals, and partnerships with public health organizations.
Segments Analysis
By Product Type
- Whole-cell Pertussis Vaccine (wP) – Traditional formulation, ~78% effective, widely used in developing countries due to lower cost.
- Acellular Pertussis Vaccine (aP) – Modern formulation, ~71% effective, preferred in developed countries for reduced side effects.
- Combination Vaccines (DTaP, Tdap, etc.) – Integrated with diphtheria and tetanus vaccines, widely adopted in pediatric immunization schedules.
By Application
- Pediatric Vaccination – Primary segment, accounting for the majority of demand.
- Adolescent & Adult Boosters – Increasing adoption to prevent outbreaks in older populations.
- Travel & Special Risk Groups – Vaccination for healthcare workers, travelers, and immunocompromised individuals.
Regional Analysis
- North America – Strong demand driven by booster vaccination programs and advanced healthcare infrastructure.
- Europe – Significant adoption in Germany, UK, and France; focus on acellular vaccines and combination formulations.
- Asia-Pacific – Fastest-growing region; China, India, and Japan drive growth due to large pediatric populations and government immunization initiatives.
- South America – Brazil and Argentina show increasing adoption in national immunization programs.
- Middle East & Africa – Emerging demand in Saudi Arabia, Turkey, and South Africa, supported by WHO-backed vaccination campaigns.
Porter’s Five Forces
- Threat of New Entrants – Low; requires high R&D investment and regulatory approvals.
- Bargaining Power of Suppliers – Moderate; raw materials and specialized production facilities influence pricing.
- Bargaining Power of Buyers – High; governments and NGOs demand affordable, safe vaccines.
- Threat of Substitutes – Low; no effective alternative to vaccination for pertussis prevention.
- Industry Rivalry – High; strong competition among global and regional vaccine manufacturers.
SWOT Analysis
Strengths
- Proven efficacy in preventing pertussis.
- Wide adoption in pediatric immunization schedules.
- Established global players with strong distribution networks.
Weaknesses
- Side effects associated with whole-cell vaccines.
- High costs of acellular formulations.
- Dependence on government procurement programs.
Opportunities
- Rising demand for combination vaccines (DTaP, Tdap).
- Expansion into emerging markets with large pediatric populations.
- Growth in booster vaccination programs for adolescents and adults.
Threats
- Vaccine hesitancy in certain regions.
- Stringent regulatory requirements.
- Competition from alternative immunization technologies under development.
Trend Analysis
- Increasing adoption of acellular pertussis vaccines in developed countries.
- Rising popularity of combination vaccines for pediatric immunization.
- Growth in booster vaccination programs for adolescents and adults.
- Expansion of government-supported immunization campaigns in emerging markets.
- Development of next-generation pertussis vaccines with improved efficacy and safety.
Drivers & Challenges
Drivers
- Rising incidence of pertussis globally.
- Expanding demand for pediatric immunization programs.
- Technological advancements in vaccine formulations.
Challenges
- High costs of acellular vaccines.
- Regulatory hurdles in vaccine approvals.
- Vaccine hesitancy and misinformation in certain regions.
Value Chain Analysis
- Raw Material Suppliers – Biological cultures, adjuvants, and stabilizers.
- Manufacturers – Global and regional producers of pertussis vaccines.
- Distributors/Wholesalers – Hospital supply chains, public health agencies, and NGOs.
- Healthcare Providers – Hospitals, clinics, and immunization centers.
- End Users – Infants, children, adolescents, and adults receiving vaccination.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in acellular and combination vaccine development to meet global demand.
- Distributors: Strengthen partnerships with governments and NGOs for large-scale immunization programs.
- Investors: Focus on companies innovating in next-generation pertussis vaccines.
- Policy Makers: Support affordable access to vaccines through public health initiatives.
- Healthcare Providers: Promote booster vaccination programs to reduce outbreaks in older populations.
Table of Contents
Global Pertussis Vaccine Market Research Report 2026
1 Industry Overview of Pertussis Vaccine
1.1 Definition and Specifications of Pertussis Vaccine
1.1.1 Definition of Pertussis Vaccine
1.1.2 Specifications of Pertussis Vaccine
1.2 Classification of Pertussis Vaccine
1.2.1 Whole-cell vaccines
1.2.2 Acellular vaccines
1.3 Applications of Pertussis Vaccine
1.3.1 Children
1.3.2 Adults
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Pertussis Vaccine
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pertussis Vaccine
2.3 Manufacturing Process Analysis of Pertussis Vaccine
2.4 Industry Chain Structure of Pertussis Vaccine
3 Technical Data and Manufacturing Plants Analysis of Pertussis Vaccine
3.1 Capacity and Commercial Production Date of Global Pertussis Vaccine Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Pertussis Vaccine Major Manufacturers
3.3 R&D Status and Technology Source of Global Pertussis Vaccine Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Pertussis Vaccine Major Manufacturers
4 Global Pertussis Vaccine Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Pertussis Vaccine Capacity and Growth Rate Analysis
4.2.2 Pertussis Vaccine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Pertussis Vaccine Sales and Growth Rate Analysis
4.3.2 Pertussis Vaccine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Pertussis Vaccine Sales Price
4.4.2 Pertussis Vaccine Sales Price Analysis (Company Segment)
5 Pertussis Vaccine Regional Market Analysis
5.1 North America Pertussis Vaccine Market Analysis
5.1.1 North America Pertussis Vaccine Market Overview
5.1.2 North America E Pertussis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Pertussis Vaccine Sales Price Analysis
5.1.4 North America Pertussis Vaccine Market Share Analysis
5.2 Europe Pertussis Vaccine Market Analysis
5.2.1 Europe Pertussis Vaccine Market Overview
5.2.2 Europe E Pertussis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Pertussis Vaccine Sales Price Analysis
5.2.4 Europe Pertussis Vaccine Market Share Analysis
5.3 China Pertussis Vaccine Market Analysis
5.3.1 China Pertussis Vaccine Market Overview
5.3.2 China E Pertussis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Pertussis Vaccine Sales Price Analysis
5.3.4 China Pertussis Vaccine Market Share Analysis
5.4 Japan Pertussis Vaccine Market Analysis
5.4.1 Japan Pertussis Vaccine Market Overview
5.4.2 Japan E Pertussis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Pertussis Vaccine Sales Price Analysis
5.4.4 Japan Pertussis Vaccine Market Share Analysis
5.5 Southeast Asia Pertussis Vaccine Market Analysis
5.5.1 Southeast Asia Pertussis Vaccine Market Overview
5.5.2 Southeast Asia E Pertussis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Pertussis Vaccine Sales Price Analysis
5.5.4 Southeast Asia Pertussis Vaccine Market Share Analysis
5.6 India Pertussis Vaccine Market Analysis
5.6.1 India Pertussis Vaccine Market Overview
5.6.2 India E Pertussis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Pertussis Vaccine Sales Price Analysis
5.6.4 India Pertussis Vaccine Market Share Analysis
6 Global E Pertussis Vaccine Segment Market Analysis (by Type)
6.1 Global E Pertussis Vaccine Sales by Type
6.2 Different Types of Pertussis Vaccine Product Interview Price Analysis
6.3 Different Types of Pertussis Vaccine Product Driving Factors Analysis
6.3.1 Whole-cell vaccines Growth Driving Factor Analysis
6.3.2 Acellular vaccines Growth Driving Factor Analysis
7 Global E Pertussis Vaccine Segment Market Analysis (by Application)
7.1 Global E Pertussis Vaccine Consumption by Application
7.2 Different Application of Pertussis Vaccine Product Interview Price Analysis
7.3 Different Application of Pertussis Vaccine Product Driving Factors Analysis
7.3.1 Children of Pertussis Vaccine Growth Driving Factor Analysis
7.3.2 Adults of Pertussis Vaccine Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Pertussis Vaccine
8.1 Sanofi Pasteur
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Sanofi Pasteur Pertussis Vaccine Business Region Distribution Analysis
8.2 GSK
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 GSK Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 GSK Pertussis Vaccine Business Region Distribution Analysis
8.3 Mitsubishi Tanabe Pharma
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Business Region Distribution Analysis
8.4 Astellas Pharma
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Astellas Pharma Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Astellas Pharma Pertussis Vaccine Business Region Distribution Analysis
8.5 Minhai Biotechnology
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Minhai Biotechnology Pertussis Vaccine Business Region Distribution Analysis
8.6 Wuhan Institute of Biological Products
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Wuhan Institute of Biological Products Pertussis Vaccine Business Region Distribution Analysis
8.7 Changchun Changsheng Life Sciences
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Changchun Changsheng Life Sciences Pertussis Vaccine Business Region Distribution Analysis
9 Development Trend of Analysis of Pertussis Vaccine Market
9.1 Global Pertussis Vaccine Market Trend Analysis
9.1.1 Global Pertussis Vaccine Market Size (Volume and Value) Forecast
9.1.2 Global Pertussis Vaccine Sales Price Forecast
9.2 Pertussis Vaccine Regional Market Trend
9.2.1 North America Pertussis Vaccine Consumption Forecast
9.2.2 Europe Pertussis Vaccine Consumption Forecast
9.2.3 China Pertussis Vaccine Consumption Forecast
9.2.4 Japan Pertussis Vaccine Consumption Forecast
9.2.5 Southeast Asia Pertussis Vaccine Consumption Forecast
9.2.6 India Pertussis Vaccine Consumption Forecast
9.3 Pertussis Vaccine Market Trend (Product Type)
9.4 Pertussis Vaccine Market Trend (Application)
10 Pertussis Vaccine Marketing Type Analysis
10.1 Pertussis Vaccine Regional Marketing Type Analysis
10.2 Pertussis Vaccine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Pertussis Vaccine by Region
10.4 Pertussis Vaccine Supply Chain Analysis
11 Consumers Analysis of Pertussis Vaccine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Pertussis Vaccine Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Pertussis Vaccine
Table Product Specifications of Pertussis Vaccine
Table Classification of Pertussis Vaccine
Figure Global Production Market Share of Pertussis Vaccine by Type in
Figure Whole-cell vaccines Picture
Table Major Manufacturers of Whole-cell vaccines
Figure Acellular vaccines Picture
Table Major Manufacturers of Acellular vaccines
Table Applications of Pertussis Vaccine
Figure Global Consumption Volume Market Share of Pertussis Vaccine by Application in
Figure Children Examples
Table Major Consumers in Children
Figure Adults Examples
Table Major Consumers in Adults
Figure Market Share of Pertussis Vaccine by Regions
Figure North America Pertussis Vaccine Market Size (Million USD) (2013-2025)
Figure Europe Pertussis Vaccine Market Size (Million USD) (2013-2025)
Figure China Pertussis Vaccine Market Size (Million USD) (2013-2025)
Figure Japan Pertussis Vaccine Market Size (Million USD) (2013-2025)
Figure Southeast Asia Pertussis Vaccine Market Size (Million USD) (2013-2025)
Figure India Pertussis Vaccine Market Size (Million USD) (2013-2025)
Table Pertussis Vaccine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Pertussis Vaccine in
Figure Manufacturing Process Analysis of Pertussis Vaccine
Figure Industry Chain Structure of Pertussis Vaccine
Table Capacity and Commercial Production Date of Global Pertussis Vaccine Major Manufacturers
Table Manufacturing Plants Distribution of Global Pertussis Vaccine Major Manufacturers
Table R&D Status and Technology Source of Global Pertussis Vaccine Major Manufacturers
Table Raw Materials Sources Analysis of Global Pertussis Vaccine Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Pertussis Vaccine E
Figure Global E Pertussis Vaccine Market Size (Volume) and Growth Rate
Figure Global E Pertussis Vaccine Market Size (Value) and Growth Rate
Table E Global Pertussis Vaccine Capacity and Growth Rate
Table Global Pertussis Vaccine Capacity (K Doses) List (Company Segment)
Table E Global Pertussis Vaccine Sales (K Doses) and Growth Rate
Table Global Pertussis Vaccine Sales (K Doses) List (Company Segment)
Table E Global Pertussis Vaccine Sales Price (USD/Doses)
Table Global Pertussis Vaccine Sales Price (USD/Doses) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Doses) of Pertussis Vaccine E
Figure North America E Pertussis Vaccine Sales Price (USD/Doses)
Figure North America Pertussis Vaccine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Doses) of Pertussis Vaccine E
Figure Europe E Pertussis Vaccine Sales Price (USD/Doses)
Figure Europe Pertussis Vaccine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Doses) of Pertussis Vaccine E
Figure China E Pertussis Vaccine Sales Price (USD/Doses)
Figure China Pertussis Vaccine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Doses) of Pertussis Vaccine E
Figure Japan E Pertussis Vaccine Sales Price (USD/Doses)
Figure Japan Pertussis Vaccine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Doses) of Pertussis Vaccine E
Figure Southeast Asia E Pertussis Vaccine Sales Price (USD/Doses)
Figure Southeast Asia Pertussis Vaccine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Doses) of Pertussis Vaccine E
Figure India E Pertussis Vaccine Sales Price (USD/Doses)
Figure India Pertussis Vaccine Sales Market Share
Table Global E Pertussis Vaccine Sales (K Doses) by Type
Table Different Types Pertussis Vaccine Product Interview Price
Table Global E Pertussis Vaccine Sales (K Doses) by Application
Table Different Application Pertussis Vaccine Product Interview Price
Table Sanofi Pasteur Information List
Table Product Overview
Table Sanofi Pasteur Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure Sanofi Pasteur Pertussis Vaccine Business Region Distribution
Table GSK Information List
Table Product Overview
Table GSK Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure GSK Pertussis Vaccine Business Region Distribution
Table Mitsubishi Tanabe Pharma Information List
Table Product Overview
Table Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure Mitsubishi Tanabe Pharma Pertussis Vaccine Business Region Distribution
Table Astellas Pharma Information List
Table Product Overview
Table Astellas Pharma Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure Astellas Pharma Pertussis Vaccine Business Region Distribution
Table Minhai Biotechnology Information List
Table Product Overview
Table Minhai Biotechnology Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure Minhai Biotechnology Pertussis Vaccine Business Region Distribution
Table Wuhan Institute of Biological Products Information List
Table Product Overview
Table Wuhan Institute of Biological Products Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Business Region Distribution
Table Changchun Changsheng Life Sciences Information List
Table Product Overview
Table Changchun Changsheng Life Sciences Pertussis Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Doses)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Business Region Distribution
Figure Global Pertussis Vaccine Market Size (K Doses) and Growth Rate Forecast
Figure Global Pertussis Vaccine Market Size (Million USD) and Growth Rate Forecast
Figure Global Pertussis Vaccine Sales Price (USD/Doses) Forecast
Figure North America Pertussis Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure China Pertussis Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Europe Pertussis Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Southeast Asia Pertussis Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Japan Pertussis Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure India Pertussis Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Table Global Sales Volume (K Doses) of Pertussis Vaccine by Type
Table Global Consumption Volume (K Doses) of Pertussis Vaccine by Application
Table Traders or Distributors with Contact Information of Pertussis Vaccine by Region
Key Players
In addition to the listed manufacturers, the following companies are also significant participants in the global pertussis vaccine market:
- GlaxoSmithKline Plc (UK)
- Sanofi Pasteur (France)
- Pfizer Inc. (US)
- Novartis AG (Switzerland)
- Emergent BioSolutions (US)
- China National Biotec Group (China)
- Serum Institute of India Pvt. Ltd. (India)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Biological E Limited (India)
- Panacea Biotec (India)
These players compete on vaccine efficacy, distribution networks, regulatory approvals, and partnerships with public health organizations.
Segments Analysis
By Product Type
- Whole-cell Pertussis Vaccine (wP) – Traditional formulation, ~78% effective, widely used in developing countries due to lower cost.
- Acellular Pertussis Vaccine (aP) – Modern formulation, ~71% effective, preferred in developed countries for reduced side effects.
- Combination Vaccines (DTaP, Tdap, etc.) – Integrated with diphtheria and tetanus vaccines, widely adopted in pediatric immunization schedules.
By Application
- Pediatric Vaccination – Primary segment, accounting for the majority of demand.
- Adolescent & Adult Boosters – Increasing adoption to prevent outbreaks in older populations.
- Travel & Special Risk Groups – Vaccination for healthcare workers, travelers, and immunocompromised individuals.
Regional Analysis
- North America – Strong demand driven by booster vaccination programs and advanced healthcare infrastructure.
- Europe – Significant adoption in Germany, UK, and France; focus on acellular vaccines and combination formulations.
- Asia-Pacific – Fastest-growing region; China, India, and Japan drive growth due to large pediatric populations and government immunization initiatives.
- South America – Brazil and Argentina show increasing adoption in national immunization programs.
- Middle East & Africa – Emerging demand in Saudi Arabia, Turkey, and South Africa, supported by WHO-backed vaccination campaigns.
